Last reviewed · How we verify
NCT05332756
Long-term Outcomes of Conservative Management in Patients with Moyamoya Disease and Their First-degree Relatives (LAMORA)
trial testing Conservative management in Moyamoya Disease in 400 participants. Currently enrolling.
30 November 2026
Quick facts
| Lead sponsor | Beijing Tiantan Hospital |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 400 |
| Start date | 1 May 2022 |
| Primary completion | 30 November 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across China |
Drugs / interventions tested
- Conservative management
Conditions studied
- Moyamoya Disease — all drugs for Moyamoya Disease →
Sponsor
Beijing Tiantan Hospital
Who can join
Adults 2 to 60, any sex, with Moyamoya Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to investigate the long-term outcomes of conservative management in patients with moyamoya disease and their first-degree relatives, and provide potential pathogenesis of moyamoya disease.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Medical Management of Adult Moyamoya Disease: A Review and Relevant Cases With Ischemic Events.
Bang OY, Fujimura M. · · 2025 · cited 2× · PMID 39916450 · DOI 10.5853/jos.2024.04273
Verify or expand the search:
- PubMed search for NCT05332756
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Conservative management
Trials testing the same drug.
- NCT07533253 — Rescue Distal Thrombectomy in Treatment for Persistent Distal Occlusions · NA · not yet recruiting
- NCT06861972 — Caesarean Hysterectomy Versus Conservative Management of Placenta Accreta: A Comparative Study · not yet recruiting
- NCT07494383 — Sphenopalatine Ganglion Block for Post-Dural Puncture Headache · NA · completed
- NCT05226169 — Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC) · Phase 3 · recruiting
- NCT04197271 — Management of Acutely Symptomatic Hernia · unknown
Other recruiting trials for Moyamoya Disease
Currently open trials in the same condition.
- NCT07304947 — Cardiac Index-Guided Intraoperative Hemodynamic Management in Pediatric Moyamoya Surgery · NA · recruiting
- NCT07140731 — The Symani Restore Study · NA · recruiting
- NCT07144930 — Cognitive-Motor Incorporated Training and Its Relations in Cerebrovascular Diseases With Cognitive and Motor Impairments · NA · recruiting
- NCT07065409 — Treatment of Moyamoya Disease With iPSC-derived Exosomes · Phase 1 · recruiting
- NCT06832839 — Study on the Mechanism of Cognitive Impairment in Patients with Moyamoya Disease · recruiting
Other Beijing Tiantan Hospital trials
Trials by the same sponsor.
- NCT07341854 — Dexamethasone Palmitate for Postoperative Pain · NA · not yet recruiting
- NCT07527013 — Stratified Blood Pressure Management Strategy After Endovascular Treatment for Acute Ischemic Stroke · Phase 3 · not yet recruiting
- NCT07520370 — Effect of Perioperative Ulinastatin on Postoperative Stroke in Patients With Brain Tumor · NA · not yet recruiting
- NCT07526987 — Efficacy and Safety of Minocycline in Patients With Acute Ischaemic Stroke Receiving Intravenous Thrombolysis · Phase 3 · not yet recruiting
- NCT07591207 — The Efficacy and Safety of Loxoprofen Sodium Patch in Relieving Postoperative Pain After Laparoscopic Surgery · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05332756 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beijing Tiantan Hospital
- Last refreshed: 19 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05332756.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing